Pregled bibliografske jedinice broj: 221181
Different expression of integrins and ICAMs in peripheral blood, lymph nodes and bone marrow in B-CLL
Different expression of integrins and ICAMs in peripheral blood, lymph nodes and bone marrow in B-CLL // LEUKEMIA & LYMPHOMA / Fatih, Uckun ; Aaron Polliack (ur.).
London : Delhi: Taylor & Francis, 2005. (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 221181 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Different expression of integrins and ICAMs in peripheral blood, lymph nodes and bone marrow in B-CLL
Autori
Jakšić, Ozren ; Kardum-Paro, Mirjana ; Kardum-Skelin, Ika ; Kušec, Rajko ; Pejša, Vlatko ; Jakšić, Branimir
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
LEUKEMIA & LYMPHOMA
/ Fatih, Uckun ; Aaron Polliack - London : Delhi : Taylor & Francis, 2005
Skup
XI International Workshop on CLL
Mjesto i datum
Sjedinjene Američke Države, 16.09.2005. - 18.09.2005
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
adhesion molecules; CLL
Sažetak
B-CLL patients have variable tumor mass distribution within major cell compartments, and as a consequence different clinical presentation. To evaluate role of integrins and their ligands ICAMs in homing of B-CLL lymphocytes to various lymphoid compartments we have evaluated the expression of integrins (CD11a, CD11b, CD11c, CD18, CD29, CD49c, CD49d and CD61) and ICAMs (CD54, CD102 and CD50) in 33 B-CLL patients in samples taken from peripheral blood (PB), bone marrow (BM) and lymph nodes (LN) by two/three color flow cytometry (on CD19 positive cells). We found stronger expression in PB than in BM for CD11a and CD102, while CD54 was stronger in BM than in PB (p<0, 05). CD11b and CD102 were stronger in PB than in LN, contrary to CD54 (p<0, 05). CD102 was stronger in BM than in LN, contrary to CD18, CD11a and CD11c (p<0, 05). By calculating logarithmic values of MFI ratios between two compartments for respective integrin or ICAM, differences were quantified and their relationships with clinical and laboratory parameters were evaluated. We found strong positive correlations of LN to PB ratio for CD11a, CD11b and CD18 with peripheral blood lymphocytosis (p<0, 05). Lymph node size was negatively correlated with LN to PB ratio for CD11b and with BM to PB ratio for CD54 and CD61 (p<0, 05). Spleen size was negatively correlated with BM to PB ratio for CD11c and CD102 (p<0, 05). BM insufficiency was associated with significantly higher BM to PB ratio for CD18, CD11a, CD11c, CD49d, CD54 and CD102, and with lower LN to PB ratio for CD102 (p<0, 05). This study shows that expression of selected integrins and ICAMs on B-CLL cells is significantly different among lymphoid compartments. Multiple associations with clinical and/or laboratory parameters with quantified differences in integrin and ICAM expression between compartments indicate their possible role in resulting clinical presentation. Taking together, adopted investigation approach proved feasible, disclosed yet unexplained interesting interactions and warrants further studies.
Izvorni jezik
Engleski
POVEZANOST RADA
Projekti:
0108107
Ustanove:
Klinička bolnica "Merkur",
Klinička bolnica "Dubrava"
Profili:
Ozren Jakšić
(autor)
Ika Kardum-Skelin
(autor)
Branimir Jakšić
(autor)
Vlatko Pejša
(autor)
Rajko Kušec
(autor)
Mirjana Mariana Kardum-Paro
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE